Le marché des enzymes, kits et réactifs de biologie moléculaire devrait être évalué à 15 715,48 USD millions en 2022 et il devrait atteindre 41 104,71 millions de dollars US d'ici 2028 ; il devrait croître à un TCAC de 17,8 % de 2022 à 2028.
Les enzymes biologiques jouent un rôle de premier plan en encourageant les réactions chimiques dans les systèmes biologiques. Les enzymes de biologie moléculaire sont recommandées pour la préparation des échantillons de laboratoire. Ces réactifs sont également utilisés au cours de divers processus tels que la réaction en chaîne par polymérase (PCR), le séquençage de l'ADN et l'analyse cellulaire. La croissance du marché est attribuée à quelques facteurs clés tels que le financement sain de la génomique, la baisse du coût des procédures de séquençage et la prévalence croissante des maladies chroniques. Cependant, la pénurie de professionnels qualifiés entrave la croissance du marché.
Le le marché des enzymes, kits et réactifs de biologie moléculaire connaît une croissance substantielle dans le contexte de la pandémie de COVID-19. La majorité des organisations de recherche en soins de santé, des acteurs du marché et des centres universitaires sont activement engagés dans les activités de recherche et développement pour développer de nouveaux vaccins et plateformes thérapeutiques pour le nouveau coronavirus qui cause le COVID-19. Cette forte augmentation des activités de recherche et développement devrait stimuler la demande de kits et de réactifs de biologie moléculaire, ce qui, à son tour, stimulera la croissance du marché des enzymes, kits et réactifs de biologie moléculaire dans les années à venir.< h3>Insights stratégiques
Régions lucratives pour le marché des enzymes, kits et réactifs de biologie moléculaire
Perspectives du marché
Un financement sain pour la génomique stimule la croissance du marché
< p>Le séquençage du génome était limité aux installations de recherche, il y a quelques années. Cependant, il est maintenant devenu l'une des techniques courantes dans les pratiques cliniques. Au cours des prochaines années, le secteur de la santé devrait générer les données génomiques de plus de 60 millions de patients. La mise en uvre croissante du séquençage génomique dans les systèmes de santé est soutenue par des investissements gouvernementaux substantiels, totalisant plus de 4 milliards de dollars américains dans au moins 14 pays. Le Royaume-Uni a annoncé le plus grand projet de génome au monde dans le cadre d'une collaboration public-privé de 200 millions entre des organisations caritatives et des sociétés pharmaceutiques. Le pays a déjà développé la plus grande base de données génomique au monde grâce au projet 100 000 génomes. Dirigé par Innovate UK, une partie de UK Research and Innovation, le projet a été lancé pour soutenir les chercheurs et les industries grâce à des fonds pour combiner des données et des preuves du monde réel obtenues auprès des services de santé britanniques ainsi que pour créer de nouveaux produits et services pour une diagnostic précoce de la maladie.
En novembre 2018, Stilla Technologies, France, a annoncé la réalisation d'un tour de financement de série A, rassemblant 18,3 millions de dollars US (16 millions d'euros) de fonds ; le cycle a été mené par Illumina Ventures. La société prévoit d'utiliser ces fonds pour la commercialisation de son système de PCR numérique Naica et le développement d'applications cliniques. De plus, en juin 2020, Base Genomics, un épigénétique
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Biological enzymes play a prominent role in encouraging chemical reactions in biological systems. Molecular biology enzymes are recommended for the preparation of laboratory samples. These reagents are also utilized during PCR, DNA sequencing, and cell analysis amongst others.
The growth of the molecular biology enzymes, kits, and reagents market is attributed to a few key driving factors such as healthy funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases.
Based on product, molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. In 2020, kits & reagents held the largest segment, and moreover, the same segment is expected to grow at the highest CAGR during the forecast period.
The sequencing segment dominated the global molecular biology enzymes, kits, and reagents market and accounted for the largest revenue of US$ 3,815.02 Mn in 2020.
Global molecular biology enzymes, kits & reagents market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global molecular biology enzymes, kits & reagents market and is expected to hold its strong foothold in the coming years. The region is expected to witness consistent growth owing to factors such as rapid sequencing technologies, increasing preference for personalized medicine, increasing competition between the market player, high R&D spending to develop new sequencing products, and sophisticated infrastructure.
The Asia Pacific region is expected to account for the fastest growth in the molecular biology enzymes, kits & reagents market. In India and China, the market is expected to grow rapidly owing to factors such as the rise in the development and research for genomics and the rise in the programs for the genomics are expected to drive the molecular biology enzymes, kits & reagents market in the forecast period. In addition, the initiatives by the government of India for the startups in biotechnology sectors.
The molecular biology enzymes, kits, and reagents market majorly consists of the players such as THERMO FISHER SCIENTIFIC INC; Illumina, Inc.; Qiagen; Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Merck KGAA; Jena Bioscience GmbH; Bioline Technologies; Promega Corporation; and Rockland Immunochemicals Inc amongst others.
The List of Companies - Molecular Biology Enzymes, Kits, and Reagents Market
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc.
- Qiagen
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Merck KGAA
- Jena Bioscience GmbH
- Bioline Technologies
- Promega Corporation
- Rockland Immunochemicals Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jun 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jun 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jun 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)